| Date Filed | Type | Description |
| 04/03/2018 |
4
| HANSEN JOHN DAVID (PRESIDENT AND CEO) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Paid exercise price by delivering 4,689 shares
@ $0
Exercised 13,561 restricted stock units
@ $0 |
|
| 03/02/2018 |
SC 13D/A
| HANSEN JOHN DAVID reports a 4.8% stake in MABVAX THERAPEUTICS HOLDINGS, INC. |
| 03/02/2018 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 02/23/2018 |
4
| HANSEN JOHN DAVID (PRESIDENT AND CEO) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Granted 290,000 options to buy
@ $2.04, valued at
$591.6k
|
|
| 01/18/2018 |
4
| HANSEN JOHN DAVID (PRESIDENT AND CEO) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Sold 59,263 shares
@ $0.92, valued at
$54.5k
|
|
| 01/16/2018 |
4
| HANSEN JOHN DAVID (PRESIDENT AND CEO) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Sold 110,093 shares
@ $0.96, valued at
$105.7k
Sold 64,015 shares
@ $0.98, valued at
$62.7k
Sold 18,582 shares
@ $0.96, valued at
$17.8k
Exercised 727,210 restricted stock units
@ $0 |
|
| 10/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/06/2017 |
4
| HANSEN JOHN DAVID (PRESIDENT AND CEO) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Sold 1,100 shares
@ $2.25, valued at
$2.5k
Sold 2,450 shares
@ $2.1513, valued at
$5.3k
Sold 1,501 shares
@ $2.1475, valued at
$3.2k
|
|
| 04/04/2017 |
4
| HANSEN JOHN DAVID (PRESIDENT AND CEO) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Exercised 40,687 restricted stock units
@ $0 |
|
| 02/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/30/2016 |
4
| HANSEN JOHN DAVID (PRESIDENT AND CEO) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Granted 63,400 options to buy
@ $5, valued at
$317k
|
|
| 08/19/2016 |
4
| HANSEN JOHN DAVID (PRESIDENT AND CEO) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Bought 3,119 shares
@ $0
Bought 3,119 warrants
@ $5.55, valued at
$17.3k
Bought 3,119 warrants
@ $6.29, valued at
$19.6k
|
|
| 04/05/2016 |
4
| HANSEN JOHN DAVID (PRESIDENT AND CEO) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Paid exercise price by delivering 113,148 shares
@ $0
Exercised 301,184 restricted stock units
@ $0 |
|
| 07/18/2014 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |